Canopy Growth Corp (CGC), CURALEAF HLDGS INC by Curaleaf Hldgs Inc. (CURLF), GW Pharma (GWPH), Jazz Pharmaceuticals (JAZZ) – Samantha Gleit – Behind D…Posted by On


Feuerstein Kulick LLP was a sponsor at the Benzinga Cannabis Capital Conference on February 25-26, 2021. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only.

Navigating through the different complexities in the cannabis industry with limited liquidity sources and a state-by-state regulatory regime is time-consuming and can add an extra cost to a company’s structure. 

If a company doesn’t strategically plan ahead to address growth and capital needs, it can be detrimental in the increasingly competitive market. Thus, financial and legal planning is crucial in the evolving cannabis landscape, and having an experienced, reliable legal team can make or break a company. 

In recent months we’ve seen several high-profile transactions achieving scale through M&A activity. From names like Curaleaf Holdings Inc. (OTCQX:CURLF), Heritage Cannabis (CSE:CANN) (OTCQX:HERTF), Jazz Pharmaceuticals (NASDAQ:JAZZ) GW Pharmaceuticals (NASDAQ:GWPH), Cresco Labs (OTC:CRLBF), Canopy Growth Corp. (NASDAQ:CGC) and Indus Holding Inc. (OTCQX:INDXF) acquiring Lowell Herb Co. among others, the market will keep gaining momentum.

Without current safe banking and federal legalization, M&A is one of the only ways to scale outside of the process of applying for and winning licenses in each state where you want to operate.

Debt financing began to…

Original Author Link click here to read complete story..

Feuerstein Kulick LLP was a sponsor at the Benzinga Cannabis Capital Conference on February 25-26, 2021. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only.

Navigating through the different complexities in the cannabis industry with limited liquidity sources and a state-by-state regulatory regime is time-consuming and can add an extra cost to a company’s structure. 

If a company doesn’t strategically plan ahead to address growth and capital needs, it can be detrimental in the increasingly competitive market. Thus, financial and legal planning is crucial in the evolving cannabis landscape, and having an experienced, reliable legal team can make or break a company. 

In recent months we’ve seen several high-profile transactions achieving scale through M&A activity. From names like Curaleaf Holdings Inc. (OTCQX:CURLF), Heritage Cannabis (CSE:CANN) (OTCQX:HERTF), Jazz Pharmaceuticals (NASDAQ:JAZZ) GW Pharmaceuticals (NASDAQ:GWPH), Cresco Labs (OTC:CRLBF), Canopy Growth Corp. (NASDAQ:CGC) and Indus Holding Inc. (OTCQX:INDXF) acquiring Lowell Herb Co. among others, the market will keep gaining momentum.

Without current safe banking and federal legalization, M&A is one of the only ways to scale outside of the process of applying for and winning licenses in each state where you want to operate.

Debt financing began to…



Source link

News

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.